Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Rescigno

Showing results (191-200 of 216) with videos related to

Pageof 22
Sort By:
Cell Host & Microbe|November 27, 2024
Prenatal antibiotics reduce breast milk IgA and induce dysbiosis in mouse offspring, increasing neonatal susceptibility to bacterial sepsisCarlo Pietrasanta, Carolina Carlosama, Michela Lizier, et al.
Neoplasia (New York, N.Y.)|October 24, 2022
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patientsFederica Bellerba, Davide Serrano, Johansson Harriet, et al.
Gastro Hep Advances|February 17, 2022
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019Chiara Pozzi, Riccardo Levi, Daniele Braga, et al.
EMBO Molecular Medicine|July 21, 2025
PV-1: a novel molecular prognostic marker of distant metastases in various solid tumorsChiara Pozzi, Riccardo Sarti, Antonino Lo Cascio, et al.
Clinical and Translational Gastroenterology|July 29, 2022
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic GastritisMarco Vincenzo Lenti, Federica Facciotti, Emanuela Miceli, et al.
Frontiers in Immunology|May 29, 2024
Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and ArgentinaArnulfo Garza-Silva, Diego Rivera-Salinas, Andrea Rivera-Cavazos, et al.
Frontiers in Immunology|February 13, 2023
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boostersMaria Rescigno, Chiara Agrati, Carlo Salvarani, et al.
Nature Communications|November 4, 2023
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumorsJacopo Chiaro, Gabriella Antignani, Sara Feola, et al.
Current Issues in Molecular Biology|July 23, 2025
Microbiota Modulation of Radiosensitiveness and Toxicity in Gastrointestinal Cancers: What Radiation Oncologists Need to Know-A Review on Behalf of the Italian Association of Radiobiology (AIRB)Marco Lorenzo Bonù, Andrea Georgopulos, Marco Ramera, et al.
Nature Microbiology|January 29, 2020
Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growthElena Zagato, Chiara Pozzi, Alice Bertocchi, et al.
Pageof 22

Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
Cell Host & Microbe|November 27, 2024
Prenatal antibiotics reduce breast milk IgA and induce dysbiosis in mouse offspring, increasing neonatal susceptibility to bacterial sepsisCarlo Pietrasanta, Carolina Carlosama, Michela Lizier, et al.
Neoplasia (New York, N.Y.)|October 24, 2022
Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patientsFederica Bellerba, Davide Serrano, Johansson Harriet, et al.
Gastro Hep Advances|February 17, 2022
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019Chiara Pozzi, Riccardo Levi, Daniele Braga, et al.
EMBO Molecular Medicine|July 21, 2025
PV-1: a novel molecular prognostic marker of distant metastases in various solid tumorsChiara Pozzi, Riccardo Sarti, Antonino Lo Cascio, et al.
Clinical and Translational Gastroenterology|July 29, 2022
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic GastritisMarco Vincenzo Lenti, Federica Facciotti, Emanuela Miceli, et al.
Frontiers in Immunology|May 29, 2024
Effectiveness of different booster vaccine combinations against SARS-CoV-2 during a six-month follow-up in Mexico and ArgentinaArnulfo Garza-Silva, Diego Rivera-Salinas, Andrea Rivera-Cavazos, et al.
Frontiers in Immunology|February 13, 2023
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boostersMaria Rescigno, Chiara Agrati, Carlo Salvarani, et al.
Nature Communications|November 4, 2023
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumorsJacopo Chiaro, Gabriella Antignani, Sara Feola, et al.
Current Issues in Molecular Biology|July 23, 2025
Microbiota Modulation of Radiosensitiveness and Toxicity in Gastrointestinal Cancers: What Radiation Oncologists Need to Know-A Review on Behalf of the Italian Association of Radiobiology (AIRB)Marco Lorenzo Bonù, Andrea Georgopulos, Marco Ramera, et al.
Nature Microbiology|January 29, 2020
Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growthElena Zagato, Chiara Pozzi, Alice Bertocchi, et al.
Pageof 22